Close

Sucampo Pharma (SCMP) Tops Q2 EPS by 1c

August 3, 2016 8:09 AM EDT

Sucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.23, $0.01 better than the analyst estimate of $0.22. Revenue for the quarter came in at $52 million versus the consensus estimate of $48.61 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings